These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7721974)

  • 21. Haemodynamic effects of enalaprilat on portal hypertension in patients with HBsAg-positive cirrhosis.
    Chiang HT; Cheng JS; Lin M; Tseng WS; Chang JM; Lai KH
    J Gastroenterol Hepatol; 1995; 10(3):256-60. PubMed ID: 7548800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis.
    Lin HC; Tsai YT; Lee FY; Chang TT; Wang SS; Lay CS; Lee SD; Lo KJ
    J Hepatol; 1990 May; 10(3):370-4. PubMed ID: 2114437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect and mechanism of action of isosorbide-5-mononitrate.
    Hayes PC; Westaby D; Williams R
    Gut; 1988 Jun; 29(6):752-5. PubMed ID: 3384359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis.
    Grose RD; Plevris JN; Redhead DN; Bouchier IA; Hayes PC
    J Hepatol; 1994 Apr; 20(4):542-7. PubMed ID: 8051395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitroglycerin for portal hypertension. A controlled comparison of the hemodynamic effects of graded doses.
    Rector WG; Hossack KF; Ready JB
    J Hepatol; 1990 May; 10(3):375-80. PubMed ID: 2114438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic changes in patients with portal venous obstruction.
    Lebrec D; Bataille C; Bercoff E; Valla D
    Hepatology; 1983; 3(4):550-3. PubMed ID: 6862366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effects of cimetidine on splanchnic hemodynamics in cirrhotic patients with portal hypertension].
    Li S
    Zhonghua Wai Ke Za Zhi; 1993 Apr; 31(4):207-9. PubMed ID: 8275833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension.
    Westaby D; Gimson A; Hayes PC; Williams R
    Gut; 1988 Mar; 29(3):372-7. PubMed ID: 3128465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of propranolol on hepatic and systemic hemodynamics in dogs with chronic bile duct ligation.
    Willems B; Villeneuve JP; Huet PM
    Hepatology; 1986; 6(1):92-7. PubMed ID: 3484714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral administration of nipradilol and the acute and chronic splanchnic hemodynamic effects of a new beta-blocker with nitrovasodilating properties in patients with liver cirrhosis.
    Sugano S; Kawafune T; Suzuki T; Kubota M; Okajima T; Sumino Y; Akita H
    Am J Gastroenterol; 1995 May; 90(5):788-93. PubMed ID: 7733089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis.
    García-Pagán JC; Feu F; Luca A; Fernández M; Pizcueta P; Bosch J; Rodés J
    J Hepatol; 1994 Jun; 20(6):792-6. PubMed ID: 7930480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
    Castaño G; Viudez P; Sookoian S; Carlevaro O; Riccitelli M; Frider B
    Gastroenterol Hepatol; 2000; 23(6):275-81. PubMed ID: 15324622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD
    Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
    Garcia-Pagán JC; Navasa M; Bosch J; Bru C; Pizcueta P; Rodés J
    Hepatology; 1990 Feb; 11(2):230-8. PubMed ID: 2307401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of hepatic and systemic haemodynamics following somatostatin administration in patients with hepatitis B-related cirrhosis.
    Hsia HC; Lin HC; Lee FY; Tsai YT; Lee SD; Meng HC; Chao Y; Wang SS; Lo KJ
    J Gastroenterol Hepatol; 1993; 8(1):15-20. PubMed ID: 8094983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of somatostatin on splanchnic haemodynamics in patients with liver cirrhosis.
    Eriksson LS; Law DH; Sato Y; Wahren J
    Clin Physiol; 1984 Feb; 4(1):5-11. PubMed ID: 6141861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hemodynamic effect of verapamil on portal hypertension in patients with postnecrotic cirrhosis.
    Kong CW; Lay CS; Tsai YT; Yeh CL; Lai KH; Lee SD; Lo KJ; Chiang BN
    Hepatology; 1986; 6(3):423-6. PubMed ID: 3710430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis.
    Sarin SK; Sethi KK; Nanda R
    Gut; 1987 Mar; 28(3):260-6. PubMed ID: 3570030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
    Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
    Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis.
    Mastai R; Bosch J; Navasa M; Kravetz D; Bruix J; Viola C; Rodés J
    J Hepatol; 1987 Feb; 4(1):71-9. PubMed ID: 3033061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.